Top MedTech Startups in the Netherlands

The Netherlands has emerged as one of Europe’s most dynamic hubs for medical technology innovation, combining world-class research institutions, a collaborative healthcare ecosystem, and strong government support for entrepreneurship. Dutch MedTech startups are at the forefront of developing groundbreaking solutions in areas ranging from AI-powered diagnostics and personalised medicine to medical devices and digital health platforms. With cities like Eindhoven, Amsterdam, and Utrecht fostering thriving innovation clusters, the country has created an ideal environment for startups to develop, test, and scale their healthcare technologies. 

Why is the Netherlands a Leading MedTech Innovation Hub?

The Netherlands stands out as a leading MedTech innovation centre, thanks to its distinctive “Quadruple Helix” model that promotes vigorous cooperation among academia, industry, government, and the public. The country serves as a living lab for the rapid development and scaling of medical innovations, propelled by prestigious research universities, a dense network of high-tech resources, and a conducive regulatory framework.

What Technologies are Dutch MedTech Startups Focusing On?

Dutch MedTech startups are concentrating significantly on artificial intelligence (AI) for purposes such as diagnostics, AI/ML diagnostics, remote monitoring, and advanced imaging. Key domains encompass AI-driven medical imaging, telemedicine, wearable sensors for patient monitoring, and robotic surgery, often utilising advanced hardware and cloud solutions. 

Top Medtech Startups in the Netherlands

The Netherlands is a leading hub in MedTech startups and has some of the best startups to keep an eye on. Here’s a list of the top Medtech startups in the Netherlands:

1. Leyden Labs

Nasal sprays with antibodies aimed at respiratory viruses in the nasal mucosa are being developed by Layden Labs. The goal of these sprays is to halt the initial infection at the entry point: this can avert further transmission, offer broad protection against both existing and novel viruses, and ensure universal defence, irrespective of a person’s immune history or pre-existing conditions.

With their offerings, anyone can combat viruses at the locations of their attacks against us, gearing us up for future endemic and pandemic dangers.

2. Pan Cancer T

​​Pan Cancer T is a startup focused on revolutionising cancer therapy via innovative science. They aim to create innovative TCR-T cell therapies that enable the immune cells of every patient to identify, assault, and conquer even the most formidable solid tumours.

3. VectorY Therapeutics

Antibody therapies can be applied broadly to neurodegenerative diseases, which are recognised as complex and challenging to treat. The state-of-the-art vectorised antibody technology developed by VectorY Therapeutics combines the use of highly selective therapeutic antibodies with a single AAV-based delivery to the CNS. They are promoting the development of a pipeline of potential disease-modifying treatments for ALS, Huntington’s, and Parkinson’s diseases.

4. Kynexis

Kynexis is developing the first potential precision medicine aimed at treating cognitive impairment associated with schizophrenia (CIAS). Their mission is to reinstate brain function to improve the quality of life for those afflicted with schizophrenia

5. Healthplus

Healthplus.ai aims to facilitate proactive surgical care by providing personalised predictions and management of complications, positioning itself as the future surgical patient risk management platform. They utilise existing data as well as validated and locally recalibrated machine learning algorithms. They become part of the current workflow to assist clinical staff in providing proactive and tailored care for your patients, your hospital, and your clinical efforts. 

6. Mair Therapeutics

Mair Therapeutics is a biotech firm focused on creating treatments for neurodegenerative diseases. They concentrate mainly on Parkinson’s disease, utilising cutting-edge drug discovery technologies and extensive knowledge in ion channel biology.

Mair Therapeutics seeks to provide disease-modifying therapies targeting the underlying causes of Parkinson’s and enhancing patients’ lives by merging state-of-the-art science with creative approaches to drug development.